Back to Journals
Neuropsychiatric Disease and Treatment
Pharma, Independent Pharma Consultant, United Kingdom
Editor-in-Chief: Dr Roger M. Pinder, PhD, DSc
Dr Pinder is an independent pharma consultant based in the city of York in the UK. He advises and consults worldwide to several pharmaceutical and venture capital organizations. He is founding editor of Neuropsychiatric Disease and Treatment and of the International Journal of Wine Research. He has served as president and secretary of the International Society for Affective Disorders (ISAD), and as treasurer and councillor of the International College of Neuropsychopharmacology (CINP).
Educated in the UK and the USA at the universities of Hull and Virginia, Dr Pinder holds doctoral degrees in medicinal chemistry (PhD) and neuropsychopharmacology (DSc). He is a fellow of the British Pharmacological Society, the British Association for Psychopharmacology, the European (ECNP) and the International Colleges of Neuropsychopharmacology (CINP), and of ISAD, and serves on the editorial board of Medicinal Chemistry Research. His professional research interests include cardiovascular and CNS pharmacology and therapeutics, with a special emphasis on depressive disorders, anti-depressants and the health benefits of wine. He is a regular speaker and chair at international congresses, and has published five books and more than 250 review and research articles.
After a long career in R&D and medical affairs management in the international pharmaceutical industry, DrPinder is now a board member of a number of start-up pharmaceutical companies.
Department of Psychiatry, Fujita Health University School of Medicine, Japan
Associate Editor - Japan: Dr Taro Kishi
Dr. Kishi has been practicing at the Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan, since 2002. In 2010 and 2011, he spent two years as a postdoctoral research fellow at the Zucker Hillside Hospital in New York. Dr. Kishi is a senior lecturer at the Department of Psychiatry, Fujita Health University School of Medicine. Dr. Kishi has been performing a series of clinical trials for the treatment of schizophrenia and mood disorder. His research focus is also evidence-based medicine in schizophrenia and mood disorder with a focus on meta-analyses. Moreover, He has a research interest in psychiatric genetics, pharmacogenetics, compliance enhancement strategies and medical decision making. He has authored/co-authored more than 120 articles.
department of psychiatry, the affiliated brain hospital of Guangzhou medical university, China (PRC)
Associate Editor: Yuping Ning
Dr. Yuping Ning is director of the affiliated brain hospital of Guangzhou Medical University P.R.C. She is professor in neuropsychiatry and supervisor of PH.D students. She holds some positions such as member of Chinese Society of Psychiatry, Chairman of Guangdong Society of Psychiatry, member of standing committee of Guangdong Society of Neurology, etc. From 1986 to 1992, she educated in XiangYa Medical college and got MD degree there. From 1992 to 1997, she practised psychiatry in Guangzhou Brain Hospital. From 1997 to 2003, she practised and pursuited her PHD in department of Neurology, Sun Yat-Sen medical university. Her research interests are in neurodegenerative diseases(AD and PD) and depression. As a visiting scholar, she performed genetic study in Parkinson disease in Juntendo University Japan. She has published 130 papers so far.
Hojjat Adeli, Professor, The Ohio State University, Columbus, OH, USA
Kristian Barlinn, Department of Neurology, University Hospital Carl Gustav Carus, Dresden, Germany
Marlene Oscar Berman, Professor of Psychiatry, Neurology, Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts, USA
Sandra Chan, Associate Professor, Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong
Prof. Dr. Chen
Lin Chen, MD, Ph.D., Neurosurgeon, Department of Neurosurgery, Tsinghua University Yuquan Hospital, People’s Republic of China
Wai-Tong Chien, Professor, Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong.
Francesco Craig, Child Neuropsychiatry Unit, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari “Aldo Moro”, Italy
Anthony S. David, Professor of Cognitive Neuropsychiatry, Vice Dean, Academic Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, Kings College, London, UK
Andrea Fagiolini, Professor of Psychiatry, Chairman, Department of Molecular Medicine, University of Siena, Italy
Mike Isaac, Consultant and Hon Senior Lecturer in Psychiatry, South London & Maudsley NHS FT and University of London, UK
Prof. Dr. IZNAK
Andrey Iznak, Professor, Mental Health Research Centre, Moscow, Russia
Sidney H Kennedy, Professor and Arthur Sommer Rotenberg Chair in Depression and Suicide Studies, St. Michael’s Hospital and University of Toronto, Canada
Firas Kobeissy, Asst Rsrch Prof, Assoc Scientific Dir of Psychoproteomics & Nanotechnology Rsrch Ctr, Dept of Psychiatry, The Evelyn F & William L McKnight Brain Institute, University of Florida, Gainesville, FL, USA
Michael Krausz, UBC-Providence Leadership Chair for Addiction Research, Professor of Psychiatry, Director Addiction Psychiatry, Institute of Mental Health, The University of British Columbia, Vancouver, BC, Canada
John S Markowitz, Professor, Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, FL, USA
Peter R. Martin, M.D., Professor of Psychiatry and Behavioral Sciences, Professor of Pharmacology, Vanderbilt Psychiatric Hospital, Vanderbilt University School of Medicine, Nashville, TN, USA
Julien Mendlewicz, Professor, Free University of Brussels, Brussels, Belgium
Prof. Dr. Mitsui
Shinichi Mitsui, Professor, Department of Rehabilitation Sciences, Gunma University Graduate School of Health Sciences, Gunma, Japan
Zoran M Pavlovic MD, Psychiatry & Neurology Consultant to Pharma/Biotech companies and CROs, Belgrade, Serbia
George Perry, Chief Scientist, Brain Health Consortium, Professor of Biology and Chemistry, College of Sciences, University of Texas at San Antonio, San Antonio, TX, USA
Steven Potkin, Professor, University of California, Irvine, USA
Norman Sartorius, MD, PhD, FRCpsych, President, Association for the Improvement of Mental Health Programmes, Switzerland
Alessandro Serretti, MD, PhD, Department of Biomedical and NeuroMotor Sciences, University of Bologna, Italy
Haowei Shen, Ph.D., Physiology & Pharmacology, Ningbo University School of Medicine, Beijing, People's Republic of China
PD Dr. Timo Siepmann, Neurologist, Site Director, Principles and Practice of Clinical Research (Harvard TH Chan School of Public Health); Director, Master's Program in Clinical Research (Dresden International University), Department of Neurology University Hospital Carl Gustav Carus Dresden, Germany
Edoardo Spina, Professor of Pharmacology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Eduard Vieta, Professor and Director of Research, Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, Spain
Ng Beng Yeong, Consultant Psychiatrist, Mount Elizabeth Medical Centre, Singapore
Nathan Zasler, CEO & Medical Director for Concussion Care Centre of Virginia, Ltd., and CEO & Medical Director for Tree of Life Services, Inc.; Clinical Professor, Department of PM&R, Virginia Commonwealth University, and Clinical Associate Professor, Department of PM&R, University of Virginia, Charlottesville, Virginia, USA